[HTML][HTML] The host immune response in respiratory virus infection: balancing virus clearance and immunopathology

AH Newton, A Cardani, TJ Braciale - Seminars in immunopathology, 2016 - Springer
The respiratory tract is constantly exposed to the external environment, and therefore, must
be equipped to respond to and eliminate pathogens. Viral clearance and resolution of …

Clinical risk factors for preeclampsia in the 21st century

…, S Parry, TF McElrath, D Pucci, A Newton… - Obstetrics & …, 2014 - journals.lww.com
OBJECTIVE: We sought to validate several clinical risk factors previously described for
preeclampsia in a large contemporary multicenter prospective cohort. METHODS: We enrolled …

Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition:  Identification of (S)-N-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl) …

…, D Harden, H He, RJ Knox, AE Newton… - Journal of medicinal …, 2003 - ACS Publications
The formation of a reactive intermediate was found to be responsible for CYP3A4
metabolism-dependent inhibition (MDI) observed with (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]-3-phenyl…

Effect of acute NR2B antagonist treatment on long-term potentiation in the rat hippocampus

JD Graef, K Newberry, A Newton, R Pieschl, E Shields… - Brain research, 2015 - Elsevier
The long lasting antidepressant response seen following acute, iv ketamine administration
in patients with treatment-resistant depression (TRD) is thought to result from enhanced …

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain

…, R Rajamani, A Easton, A Newton… - Journal of Medicinal …, 2017 - ACS Publications
By taking advantage of certain features in piperidine 4, we developed a novel series of
cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Na v 1.7 …

(S)-N-[1-(3-Morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide:  An Orally Bioavailable KCNQ2 Opener with Significant Activity in a Cortical Spreading Depression …

…, RJ Knox, J Natale, AE Newton… - Journal of medicinal …, 2003 - ACS Publications
(S)-N-[1-(3-Morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide (2) was synthesized as an
orally bioavailable KCNQ2 potassium channel opener. In a rat model of migraine, 2 …

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

G Luo, L Chen, A Easton, A Newton… - Journal of Medicinal …, 2018 - ACS Publications
3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Na v 1.7
inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also …

Low density lipoprotein promotes human naive T cell differentiation to Th1 cells

AH Newton, SH Benedict - Human Immunology, 2014 - Elsevier
Oxidized LDL (oxLDL) in the arterial wall and its incorporation into foam cells leads to
inflammation and nucleation of atherosclerotic plaque; this is opposed by HDL. OxLDL and HDL …

Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists–serotonin reuptake transporter inhibitors for the treatment of …

…, R Bertekap, R Westphal, S Lelas, A Newton… - Bioorganic & medicinal …, 2013 - Elsevier
This report describes the synthesis, structure–activity relationships and activity of piperidine,
homopiperidine, and azocane derivatives combining NK 1 receptor (NK 1 R) antagonism …

Discovery of non-zwitterionic aryl sulfonamides as Nav1. 7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron …

…, G Luo, R Rajamani, A Ng, A Easton, A Newton… - Bioorganic & Medicinal …, 2017 - Elsevier
Since zwitterionic benzenesulfonamide Na v 1.7 inhibitors suffer from poor membrane
permeability, we sought to eliminate this characteristic by replacing the basic moiety with non-…